An Intact Pericardium Ischemic Rodent Model
September 2nd, 2021
2.4K views
This protocol outlines the steps for inducing myocardial infarction in mice while preserving the pericardium and its contents.
Overview
This protocol outlines the steps for inducing myocardial infarction in mice while preserving the pericardium and its contents. This method allows for the evaluation of the role of the pericardial cavity in cardiac repair following myocardial infarction.
Key Study Components
Area of Science
- Cardiology
- Neuroscience
- Animal Models
Background
- Myocardial infarction is a critical condition affecting heart function.
- The pericardial cavity plays a significant role in cardiac repair.
- Conventional methods often compromise the pericardial cavity.
- Understanding the pericardial response can inform therapeutic strategies.
Purpose of Study
- To maintain an intact pericardial cavity during myocardial infarction modeling.
- To assess the role of pericardial contents in heart healing.
- To improve understanding of cardiac injury responses.
Methods Used
- Post-anesthetization, the mouse is restrained and positioned for surgery.
- Ventilation with 2% isoflurane and 100% oxygen is initiated.
- Specific ventilatory settings are applied for the procedure.
- Myocardial infarction is induced while preserving the pericardium.
Main Results
- The method allows for the study of pericardial contents post-infarction.
- Insights into cardiac repair mechanisms are gained.
- Potential therapeutic strategies targeting the pericardium are identified.
Conclusions
- Maintaining the pericardial cavity enhances understanding of cardiac repair.
- This method provides a novel approach to studying myocardial infarction.
- Future research can focus on therapeutic interventions involving the pericardium.
Frequently Asked Questions
What is the significance of preserving the pericardium?
Preserving the pericardium allows for a better understanding of its role in cardiac repair following injury.
How does this method differ from conventional techniques?
Unlike conventional methods, this technique maintains an intact pericardial cavity, providing insights into its contents and functions.
What are the implications of this research?
The findings could lead to new therapeutic strategies that target the pericardium to enhance heart healing.
What type of anesthesia is used in this protocol?
The protocol uses 2% isoflurane for anesthesia during the surgical procedure.
What are the ventilatory settings for the mice?
The mice are ventilated at a rate of 110 breaths per minute with a tidal volume of 250 microliters.
Can this method be applied to other animal models?
While this method is designed for mice, adaptations may be possible for other species.
Executive Industry Relevance
This model enables mechanistic de-risking of cardiovascular therapeutics by preserving the pericardial cavity and its immune cell populations during myocardial infarction. It supports target validation by allowing direct interrogation of pericardial macrophage contributions to post-infarct remodeling and fibrosis. The approach enhances predictive confidence in preclinical studies by maintaining physiological relevance often lost in conventional models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of pericardial macrophage function in cardiac repair pathways.
- Operational Value: Provides a disease-relevant system to validate targets modulating pericardial-mediated anti-fibrotic responses.
- Scientific Value: Supports phenotypic screening of compounds that enhance pericardial immune cell recruitment or activity.
Screening & Assay Development
- Scientific Value: Generates quantitative outputs via picrosirius red staining and fibrosis quantification for compound efficacy assessment.
- Operational Value: Standardizes infarct model reproducibility by minimizing pericardial disruption variability.
- Scientific Value: Enables tracking of labeled pericardial myeloid cells via flow cytometry for pharmacodynamic readouts.
Translational & Preclinical Research
- Scientific Value: Aligns with translational biomarker strategies by linking pericardial immune dynamics to ventricular remodeling.
- Operational Value: Facilitates preclinical continuity from discovery through functional and histological validation at four weeks post-infarct.
- Scientific Value: Supports risk-adjusted advancement decisions by revealing pericardial-mediated protection against adverse remodeling.
Pipeline & Workflow Integration
The model integrates into the discovery continuum from target validation through preclinical efficacy testing, particularly for immunomodulatory or anti-fibrotic candidates.
- Discovery Biology: Supports hypothesis testing of pericardial cavity contributions to ischemic injury response.
- Screening: Delivers reproducible, quantitative structural and functional readouts for compound comparison.
- Analytics: Provides echocardiography-derived ejection fraction and histology-based fibrosis quantification for efficacy assessment.
- Translational Research: Connects pericardial immune cell tracking to preclinical outcomes relevant to heart failure progression.
- Enterprise Reuse: Establishes a reusable platform for studying immunomodulatory mechanisms in cardiac repair.
Operational & Enterprise Impact
- Scientific Value: Increases target confidence by elucidating pericardial macrophage roles in limiting fibrosis.
- Operational Value: Enhances reproducibility through standardized surgical perfusion and ligation techniques.
- Strategic Value: Improves go/no-go decisions by reducing false negatives from pericardial disruption artifacts.
- Portfolio Impact: Enables risk-adjusted prioritization of therapeutics targeting pericardial-immune crosstalk.
Implementation Considerations
- Requires expertise in microsurgical techniques, including pericardium-preserving coronary ligation.
- Necessitates echocardiography and histology infrastructure for functional and structural endpoint analysis.
- Demands cross-team standardization between surgery, imaging, and histology teams for consistent infarct quantification.
- Involves adaptation considerations when combining with lineage tracing or effector blockade in different genetic backgrounds.
- Dependent on meticulous pericardial handling to prevent inadvertent disruption during surgical access.
Biopharma FAQs
Why does pericardial integrity matter for target validation in ischemic models?
Preserving the pericardial cavity maintains the homeostatic cellular milieu, including resident Gata6-positive macrophages, which modulate post-infarct fibrosis. Disruption of this milieu in conventional models obscures the pericardium's anti-fibrotic role. This model enables accurate assessment of targets influencing pericardial-mediated cardiac repair.
How does isolating the pericardial cavity as an independent variable improve discovery pipeline fidelity?
By maintaining an intact pericardial space, the model isolates the cavity's contribution to healing from ventricular injury alone. This allows researchers to attribute functional recovery differences specifically to pericardial contents. Such isolation reduces confounding variables in early target validation studies.
What quantitative dependent variable measurements enable compound screening in this model?
Left ventricle ejection fraction via echocardiography and picrosirius red-stained fibrosis quantification provide functional and structural endpoints. These measurements are assessed at three to four weeks post-infarct to capture remodeling dynamics. The dual readouts support dose-response analysis in screening campaigns.
Why are replication requirements critical for cross-functional collaboration in this model?
Consistent infarct induction with intact pericardium ensures reproducibility across laboratories and teams. Standardized ventilation settings, suture ligation, and postoperative care minimize variability. Reliable replication enables histology, imaging, and flow cytometry teams to generate comparable datasets.
What statistical analysis capabilities are required before implementing this model in preclinical studies?
The model requires capacity for longitudinal echocardiography analysis and endpoint fibrosis quantification with appropriate group sizing. Statistical comparison between intact and disrupted pericardial ligation groups depends on variance in ejection fraction and fibrosis percentage. Power analysis based on observed effect sizes supports robust preclinical study design.
